Company intelligence / Profile preview
Boiron
Messimy, Rhône, Franceboiron.com ↗
- Ownership
- Private
- Employees
- ~3600
- Development stage
- Other
01
Overview
Boiron’s products are widely available globally, but there is no robust clinical evidence supporting efficacy beyond placebo for its homeopathic medicines. The company has faced legal challenges regarding product claims but remains a market leader in its segment.
- Therapeutic areas
- OtherNeurologyInfectious Diseases
- Modalities
- Homeopathic medicines (including mono-preparations and poly-preparations)
- Industry
- Biotech
02
Drug pipeline
24 assets23 more assets in the full pipeline.
03
Partnerships
Partnerships primarily with distributors and healthcare professionals worldwide. No major pharma/biotech R&D partnerships reported.
Beyond the preview
Go deeper on Boiron.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Boiron.